Enter the era ofVarian ProtonTherapy...
Transcript of Enter the era ofVarian ProtonTherapy...
Enter the era of Varian Proton Therapy
USA Headquarters
Palo Alto, CA
Telephone: 650.424.5700
Toll Free: 800.544.4636
Latin American Headquarters
Miami, FL USA
Telephone: 305.929.1970
RAD 9999A Copyright © 2008 Varian Medical Systems, Inc. Printed in USA. 08/08
Varian and Varian Medical Systems are registered trademarks of Varian Medical Systems, Inc. The names of other companies and products herein
are used for identification purposes only and may be trademarks or registed trademarks of their respective owners.
European Headquarters
International AG
Zug, Switzerland
Telephone: 41.41.749.884
Bergisch Gladbach, Germany
Telephone: 49.22.04.842500
Fax: 49.22.04.842501
Asian Headquarters
Pacific, Inc.
Kowloon, Hong Kong
Telephone: 85.22.724.2836
Australian Headquarters
Australasia Pty Ltd.
Sydney, Australia
Telephone: 61.2.9485.0100
www. varian.com
VARIAN MEDICAL SYSTEMS PARTICLE THERAPY
Disclaimer
The proton therapy device technology described in this
brochure has not been cleared by the US Food and Drug
Administration (“FDA”) for clinical use and is in development.
The FDA has a unique set of standards for proton therapy
devices because the entire proton therapy facility must be
built for the specific device. For these types of devices, the
FDA allows proton therapy sponsors to discuss projects with
potential customers and to engage in contracts /orders to
build proton therapy facilities and /or to purchase proton
therapy equipment. However, contracts or other engagements
specific to clinical practice are strictly prohibited; that is, no
engagements or agreements for patient scheduling or
physician group practice to use proton therapy equipment are
permitted in advance of FDA clearance.
For over 50 years Varian has led the way in cancer
treatment, introducing innovative solutions and launching
technologies that have revolutionized treatment. While we
take great pride in our success, we attribute much of it to
our close collaboration with clinical experts. Their involvement,
coupled with our dedication to excellence, has produced
a history of results that is simply unmatched in the
industry. • Now, Varian expands its cancer treatment
offering with the first and only fully Varian compatible
Proton Therapy system from a single vendor. System
compatibility means true integration, resulting in more
time for your clinical staff to focus on patients and
innovative care. • For more than a decade, Varian has been
making significant advances in the proton therapy field,
being the first to bring proton therapy treatment
planning to the U.S. market. When you partner with
Varian, you choose the undisputed leader in oncology
solutions enabling you to maintain your status as a member
of the select medical community that is leading the way
in cancer care.
Varian’s Proton Therapy Development Program a milestone in cancer treatment
F U T U R E C H O R E O G R A P H E R
When your facility is among the world’s top cancer
treatment centers, your next decision-making step is
relatively easy. In order to continue to be the best at
what you do, you need to have the most advanced tools.
You seek “state-of-the-art” technology. The question is,
should you embrace emerging technologies or maintain
the status quo? The answer will undoubtedly define the
future of your facility. • The investment typically required
for a proton therapy center, along with the patient
demographics necessary to warrant such an expense,
usually prevents the establishment of many centers
within a given location. A determining fact is that
leadership roles in proton therapy cancer treatment, once
taken, will leave little or no room for others to follow.
Once a community is served, once a treatment center
establishes its reputation as a leader, other facilities tend
to recede into secondary roles. • Making the right choice
today for the future of your organization is paramount.
It’s what’s nextfor the world’s top cancer treatment centers
F U T U R E G R A N D P A R E N T
All cancer facilities, like all patients, are unique. But all
cancer facilities share the common goal of wanting to
better serve their community. Today, less than one percent
of all radiotherapy patients who could benefit significantly
from having protons for all or part of their treatment get
treated with proton therapy.* Our commitment to helping
you improve this percentage makes Varian an ideal proton
therapy partner. • Our proton therapy solution is being
developed with efficiency, cost savings and accuracy in
mind to give you a streamlined proton therapy process for
prescription, planning, scheduling, delivery, and quality
assurance. We have designed our system to be adaptive
with maximum scalability meaning that a hospital can start
small and expand as its practice grows. It is designed to
accommodate future technologies, as well as address the
needs of your facility. Larger treatment centers will find
that the Varian system is capable of servicing the most
challenging population demands as well. • In addition, this
advanced mode of therapy may present a tremendous
opportunity for your center to attract new patients and
draw additional superior talent to your facility.
An uncommon approach to common goals
* http://new.reil lycomm.com/imaging/article_detail.php?id=311
F U T U R E E N V I R O N M E N T A L R E S E A R C H E R
As a world leader in the manufacturing of medical
devices and software for treating cancer, Varian is a
company with extensive global resources. Employing
over 4,000 people, with sales exceeding 1.5 billion, Varian
is in the position of being able to develop, refine, and
service its product offerings in ways that many other
companies simply cannot. • The Proton Therapy system
from Varian stands as a perfect example of how the depth
and breadth of Varian’s resources can help solve problems,
simplify operational issues, and move cancer treatment
forward. Varian’s comprehensive Proton Therapy offering
is unique in the industry, enabling you and your staff to
link advanced proton therapy to most existing radiation
therapy services, helping to maximize efficiencies, reduce
learning curves and assure that the system availability will
be maintained at a high level. • It comes down to one of
the simplest facts of healthcare: that better outcomes can
produce a more perfect world. And that’s the world we
would like to see in the not-so-distant future.
Someday, in a more perfect world, we hope everyone will have access to Varian Proton Therapy
F U T U R E N O B E L L A U R E A T E
Varian has combined its comprehensive treatment delivery, planning,
and information management system into a unique, state-of-the-art
Intensity Modulation Proton Therapy (IMPT) solution in which every
component is engineered to work together. • IMPT treatments are
critical because they enable clinicians to tailor and maximize the radi-
ation dose to a tumor, while delivering lower global dose to healthy
tissue. Optimal IMPT delivery is achieved through accurate beam
scanning. Varian’s technology permits true IMPT delivery by painting
the dose to the tumor essentially reducing neutron dose to the
patient. When you combine Varian’s superb scanning technology with
the high performance of Varian’s new 250 MeV Superconducting
Cyclotron, you obtain smooth IMPT proton delivery. • Varian’s new
250 MeV Superconducting Cyclotron is a key component of the
Varian Proton Therapy system. Its state-of-the-art design stands as a
milestone in cancer treatment allowing facilities to deliver precise
proton therapy. Its compact size requires minimal space and its
superconducting design results in high extraction efficiency, reliability,
and efficient maintenance. • In today’s market, Varian’s 250 MeV
Superconducting Cyclotron is a genuine advancement in proton
cancer therapy. Only Varian can provide you with such a sophisticated
solution backed by world-renowned customer support and more than
a half century of experience in radiation oncology.
The technology behind optimal integration, IMPT, and the Cyclotron
V A R I A N S U P E R C O N D U C T I N G C Y C L O T R O N
The proton therapy device technology described in this
brochure has not been cleared by the US Food and
Drug Administration (“FDA”) for clinical use and is in
development. The FDA has a unique set of standards for
proton therapy devices because the entire proton therapy
facility must be built for the specific device. For these types
of devices, the FDA allows proton therapy sponsors to
discuss projects with potential customers and to engage in
contracts /orders to build proton therapy facilities and /or
to purchase proton therapy equipment. However,
contracts or other engagements specific to clinical
practice are strictly prohibited; that is, no engagements
or agreements for patient scheduling or physician group
practice to use proton therapy equipment are permitted
in advance of FDA clearance.
Disclaimer
Enter the era of Varian Proton Therapy
USA Headquarters
Palo Alto, CA
Telephone: 650.424.5700
Toll Free: 800.544.4636
Latin American Headquarters
Miami, FL USA
Telephone: 305.929.1970
RAD 9999A Copyright © 2008 Varian Medical Systems, Inc. Printed in USA. 08/08
Varian and Varian Medical Systems are registered trademarks of Varian Medical Systems, Inc. The names of other companies and products herein
are used for identification purposes only and may be trademarks or registed trademarks of their respective owners.
European Headquarters
International AG
Zug, Switzerland
Telephone: 41.41.749.884
Bergisch Gladbach, Germany
Telephone: 49.22.04.842500
Fax: 49.22.04.842501
Asian Headquarters
Pacific, Inc.
Kowloon, Hong Kong
Telephone: 85.22.724.2836
Australian Headquarters
Australasia Pty Ltd.
Sydney, Australia
Telephone: 61.2.9485.0100
www. varian.com
VARIAN MEDICAL SYSTEMS PARTICLE THERAPY
Disclaimer
The proton therapy device technology described in this
brochure has not been cleared by the US Food and Drug
Administration (“FDA”) for clinical use and is in development.
The FDA has a unique set of standards for proton therapy
devices because the entire proton therapy facility must be
built for the specific device. For these types of devices, the
FDA allows proton therapy sponsors to discuss projects with
potential customers and to engage in contracts /orders to
build proton therapy facilities and /or to purchase proton
therapy equipment. However, contracts or other engagements
specific to clinical practice are strictly prohibited; that is, no
engagements or agreements for patient scheduling or
physician group practice to use proton therapy equipment are
permitted in advance of FDA clearance.